Literature DB >> 27885057

Circulating active serum calcium reduces the risk of hypertension.

Setor K Kunutsor1, Jari A Laukkanen2,3.   

Abstract

Purpose Calcium, which is one the most abundant mineral elements in the body, has been suggested to be involved in blood pressure regulation. We aimed to assess the association of active serum calcium (which is the ionised and physiologically active form of serum calcium) with the future risk of hypertension. Methods The active serum calcium concentration was assessed at baseline in the Finnish Kuopio Ischemic Heart Disease population-based prospective cohort study of 1562 normotensive men aged 42-61 years at baseline. Cox proportional hazard models were used to assess the hazard ratios (95% confidence intervals (CIs)) for incident hypertension. Results During a median follow-up of 24.9 years, 247 men developed new-onset hypertension. Active serum calcium was inversely associated with incident hypertension in an approximately linear fashion. In age-adjusted analysis, the hazard ratio for hypertension per 1 standard deviation increase in active serum calcium was 0.86 (95% CI 0.76-0.98), which remained consistent after adjustment for several established risk factors and potential confounders 0.82 (0.71-0.94). In a comparison of extreme quintiles of active serum calcium levels, the corresponding adjusted hazard ratios were 0.59 (95% CI 0.39-0.90) and 0.54 (95% CI 0.35-0.82), respectively. Conclusion Active serum calcium is protective of future hypertension in a middle-aged male Caucasian population. Further research is needed to confirm these findings and help unravel the mechanistic pathways of calcium in the pathogenesis of hypertension.

Entities:  

Keywords:  Active serum calcium; blood pressure; hypertension; risk factor

Mesh:

Substances:

Year:  2016        PMID: 27885057     DOI: 10.1177/2047487316681174

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  8 in total

1.  Associations of Plasma Copper, Magnesium, and Calcium Levels with Blood Pressure in Children: a Cross-sectional Study.

Authors:  Gengdong Chen; Yan Li; Guifang Deng; Shiksha Shrestha; Fengyan Chen; Yuanhuan Wei; Zhaochang Huang; Jialiang Pan; Zheqing Zhang
Journal:  Biol Trace Elem Res       Date:  2020-05-30       Impact factor: 3.738

2.  Circulating Serum Copper Is Associated with Atherosclerotic Cardiovascular Disease, but Not Venous Thromboembolism: A Prospective Cohort Study.

Authors:  Setor K Kunutsor; Richard S Dey; Jari A Laukkanen
Journal:  Pulse (Basel)       Date:  2021-11-19

3.  Evaluation of serum magnesium differences in hypertensive crises and control patients: A randomly matched case-control study.

Authors:  IfeanyiChukwu O Onor; Emily K Johnston; Nicole G Little; Lashira M Hill; Oluwabunmi E Lawal; Casey J Payne; Mallory R Coleman; Carolkim H Huynh; Sarah E Bilbe; Ahlam A Ayyad; Kabrea J Jones; Jasmine D Kinnard; Rosanna Dastoori; Devinn K Rolland; Amanda S Miller; Robbie A Beyl; Christopher J Gillard; John I Okogbaa; Daniel F Sarpong; Rim M Hadgu; Amne Borghol; Samuel C Okpechi; Mihran V Naljayan; Shane E Sanne; Shane G Guillory
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-05-08       Impact factor: 3.738

Review 4.  Impact of Micronutrients on Hypertension: Evidence from Clinical Trials with a Special Focus on Meta-Analysis.

Authors:  Hui-Fang Chiu; Kamesh Venkatakrishnan; Oksana Golovinskaia; Chin-Kun Wang
Journal:  Nutrients       Date:  2021-02-10       Impact factor: 5.717

5.  Association Between Serum Calcium and the Prevalence of Hypertension Among US Adults.

Authors:  Yang Hua; Heng-Li Liu; Jin-Yu Sun; Xiang-Qing Kong; Wei Sun; Ya-Qing Xiong
Journal:  Front Cardiovasc Med       Date:  2021-11-29

6.  Circulating Serum Magnesium and the Risk of Venous Thromboembolism in Men: A Long-Term Prospective Cohort Study.

Authors:  Setor K Kunutsor; Jari A Laukkanen
Journal:  Pulse (Basel)       Date:  2021-04-13

7.  Association of Serum Calcium and Insulin Resistance With Hypertension Risk: A Prospective Population-Based Study.

Authors:  Xiaoyan Wu; Tianshu Han; Jian Gao; Yunlong Zhang; Shengnan Zhao; Rongbo Sun; Changhao Sun; Yucun Niu; Ying Li
Journal:  J Am Heart Assoc       Date:  2019-01-08       Impact factor: 5.501

8.  Evaluation of serum calcium differences in hypertensive crises and control patients: A randomly matched case-control study.

Authors:  IfeanyiChukwu O Onor; Rose M Duchane; Casey J Payne; Hannah Naquin Lambert; DeMaurian M Mitchner; Robbie A Beyl; Anh T Nguyen; Sarah E Bilbe; Andrea Arriaga White; Mariah W Johnson; Amber I Faciane; Emmanuel Kouagou; Stephanie A Hymel; Bria M Wates; Asia D Sanders; Phillip C B Vo; Jordan D Bates; Raven J Spooner; Christopher J Gillard; John I Okogbaa; Daniel F Sarpong; Rim M Hadgu; Samuel C Okpechi; Gabriel I Onor; Michael C Okoronkwo; Mihran V Naljayan; Shane G Guillory; Shane E Sanne
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-07-22       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.